Showing results (91-100 of 154) with videos related to
Sort By:
Pageof 16
American Journal of Hematology|September 2, 2022
The significance of spleen size in children with sickle cell anemiaAmina Nardo-Marino, Andreas Glenthøj, John N Brewin, et al.British Journal of Haematology|June 22, 2010
Outcome of children with sickle cell disease admitted to intensive care - a single institution experienceJack L Bartram, Swee L Thein, Kate Gardner, et al.Circulation. Genomic and Precision Medicine|September 14, 2020
Genetic Analysis of Patients With Sickle Cell Anemia and Stroke Before 4 Years of Age Suggest an Important Role for Apoliprotein EJohn N Brewin, Alexander E Smith, Riley Cook, et al.Haematologica|July 3, 2009
Auto-adjusting positive airway pressure in children with sickle cell anemia: results of a phase I randomized controlled trialMelanie J Marshall, Romola S Bucks, Alexandra M Hogan, et al.British Journal of Haematology|November 12, 2005
Windy weather and low humidity are associated with an increased number of hospital admissions for acute pain and sickle cell disease in an urban environment with a maritime temperate climateSimon Jones, Edward R Duncan, Nikki Thomas, et al.Haematologica|March 12, 2010
Extracranial internal carotid arterial disease in children with sickle cell anemiaColin R Deane, David Goss, Jack Bartram, et al.ACS Medicinal Chemistry Letters|June 20, 2014
Validity of ligand efficiency metricsChristopher W Murray, Daniel A Erlanson, Andrew L Hopkins, et al.British Journal of Haematology|June 4, 2023
Significant haemoglobinopathies: A guideline for screening and diagnosis: A British Society for Haematology Guideline: A British Society for Haematology GuidelineBarbara J Bain, Yvonne Daniel, Joan Henthorn, et al.British Journal of Haematology|June 29, 2005
The measurement of urinary hydroxyurea in sickle cell anaemiaR Neil Dalton, Charles Turner, Moira Dick, et al.Pediatric Blood & Cancer|September 25, 2015
Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategyCarolyn C Hoppe, Lori Styles, Lori E Heath, et al.Pageof 16